Literature DB >> 26185211

Long-Term Outcome of Mustard/Senning Correction for Transposition of the Great Arteries in Sweden and Denmark.

Niels Vejlstrup1, Keld Sørensen2, Eva Mattsson2, Ulf Thilén2, Per Kvidal2, Bengt Johansson2, Kasper Iversen2, Lars Søndergaard2, Mikael Dellborg2, Peter Eriksson2.   

Abstract

BACKGROUND: The atrial switch operation, the Mustard or Senning operation, for the transposition of the great arteries (TGA) was introduced in the late 1950s and was the preferred surgery for TGA until the early 1990s. The Mustard and Senning operation involves extensive surgery in the atria and leaves the right ventricle as the systemic ventricle. The Mustard and Senning cohort is now well into adulthood and we begin to see the long-term outcome. METHODS AND
RESULTS: All the 6 surgical centers that performed Mustard and Senning operations in Sweden and Denmark identified all operated TGA patients. Information about death was obtained in late 2007 and early 2008 from the Danish and Swedish Centralised Civil Register by using the patients' unique national Civil Registration Numbers. Four hundred sixty-eight patients undergoing the atrial switch operation were identified. Perioperative 30-day mortality was 20%, and 60% were alive after 30 years of follow-up. Perioperative mortality was significantly increased by the presence of a ventricular septal defect, left ventricular outflow obstruction, surgery early in the Mustard and Senning era. However, only pacemaker implantation is predictive of long-term outcome (hazard ratio, 1.90; 95% confidence interval, 1.05-3.46, P=0.04), once the TGA patient has survived the perioperative period. The risk of reoperation was correlated to the presence of associated defects and where the first Mustard/Senning operation was performed.
CONCLUSIONS: The long-term survival of patients with Mustard and Senning correction for TGA appears to be primarily determined by factors in the right ventricle and tricuspid valve and not the timing of or the type of surgery in childhood. Cardiac function necessitating the implantation of a pacemaker is associated with an increase in mortality.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  heart defects, congenital; pacemaker, artificial; population; prognosis; survival; transposition of great vessels

Mesh:

Year:  2015        PMID: 26185211     DOI: 10.1161/CIRCULATIONAHA.114.010770

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  18 in total

1.  Risk markers for excess mortality in adults with congenital heart disease: does one size fit all?

Authors:  François-Pierre Mongeon; Paul Khairy
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

2.  Dextro-transposition of the great arteries: switching the switch.

Authors:  Marie-A Chaix; Paul Khairy
Journal:  Transl Pediatr       Date:  2019-12

Review 3.  Narrative review of: risk stratification and implantable cardioverter-defibrillator therapy in adults with congenital heart disease.

Authors:  Julia Köbe; Kevin Willy; Lars Eckardt; Helmut Baumgartner; Kristina Wasmer
Journal:  Cardiovasc Diagn Ther       Date:  2021-04

Review 4.  Society for Cardiovascular Magnetic Resonance/European Society of Cardiovascular Imaging/American Society of Echocardiography/Society for Pediatric Radiology/North American Society for Cardiovascular Imaging Guidelines for the Use of Cardiac Magnetic Resonance in Pediatric Congenital and Acquired Heart Disease: Endorsed by The American Heart Association.

Authors:  Mark A Fogel; Shaftkat Anwar; Craig Broberg; Lorna Browne; Taylor Chung; Tiffanie Johnson; Vivek Muthurangu; Michael Taylor; Emanuela Valsangiacomo-Buechel; Carolyn Wilhelm
Journal:  Circ Cardiovasc Imaging       Date:  2022-06-21       Impact factor: 8.589

Review 5.  Society for Cardiovascular Magnetic Resonance/European Society of Cardiovascular Imaging/American Society of Echocardiography/Society for Pediatric Radiology/North American Society for Cardiovascular Imaging Guidelines for the use of cardiovascular magnetic resonance in pediatric congenital and acquired heart disease : Endorsed by The American Heart Association.

Authors:  Mark A Fogel; Shaftkat Anwar; Craig Broberg; Lorna Browne; Taylor Chung; Tiffanie Johnson; Vivek Muthurangu; Michael Taylor; Emanuela Valsangiacomo-Buechel; Carolyn Wilhelm
Journal:  J Cardiovasc Magn Reson       Date:  2022-06-21       Impact factor: 6.903

Review 6.  [Antibradycardia therapy : Indication and implementation].

Authors:  Peter Zartner
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2016-05-24

7.  Myocardial fibrosis and its relation to adverse outcome in transposition of the great arteries with a systemic right ventricle.

Authors:  Craig S Broberg; Anne Marie Valente; Jennifer Huang; Luke J Burchill; Jonathan Holt; Ryan Van Woerkom; Andrew J Powell; George A Pantely; Michael Jerosch-Herold
Journal:  Int J Cardiol       Date:  2018-11-15       Impact factor: 4.164

8.  B-type natriuretic peptide: powerful predictor of end-stage chronic heart failure in individuals with systolic dysfunction of the systemic right ventricle.

Authors:  Marketa Hegarova; Jaroslav Brotanek; Milos Kubanek; Radka Kockova; Janka Franekova; Vera Lanska; Ivan Netuka; Vojtech Melenovsky; Ivan Malek; Josef Kautzner
Journal:  Croat Med J       Date:  2016-08-31       Impact factor: 1.351

9.  Clinical Course Long After Atrial Switch: A Novel Risk Score for Major Clinical Events.

Authors:  Odilia I Woudstra; Tjitske E Zandstra; Rosanne F Vogel; Arie P J van Dijk; Hubert W Vliegen; Philippine Kiès; Monique R M Jongbloed; Anastasia D Egorova; Pieter A F M Doevendans; Thelma C Konings; Barbara J M Mulder; Michael W T Tanck; Folkert J Meijboom; Berto J Bouma
Journal:  J Am Heart Assoc       Date:  2021-02-22       Impact factor: 5.501

10.  Late Onset Postcapillary Pulmonary Hypertension in Patients With Transposition of the Great Arteries and Mustard or Senning Baffles.

Authors:  Marie-A Chaix; Annie Dore; Lise-Andrée Mercier; François-Pierre Mongeon; François Marcotte; Réda Ibrahim; Anita W Asgar; Azadeh Shohoudi; Fabien Labombarda; Blandine Mondésert; Nancy Poirier; Paul Khairy
Journal:  J Am Heart Assoc       Date:  2017-10-12       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.